SCHEMBL25818416

SCHEMBL25818416

Clc1nc(-c2cccc(-c3ccc4c(-c5ccccc5)cc(-c5ccccc5)cc4c3)c2)nc(-c2ccc3sc4ccccc4c3c2)n1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 1/20 0.37
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
F9 P00740 3/20 0.33
LIMK1 P53667 1/20 0.33
ROCK1 Q13464 1/20 0.32
CYP1A2 P05177 1/20 0.32
NR1I3 Q14994 1/20 0.31
GPR3 P46089 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PTPN1 P18031 1/20 0.31
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818506 0.98 PIM3 (0.39) PIM3HSD17B1HSD17B2F9LIMK1
SCHEMBL25817707 0.93 PIM3 (0.40) PIM3HSD17B1HSD17B2F9LIMK1
SCHEMBL25818386 0.91 F9 (0.38) PIM3HSD17B1HSD17B2F9CYP1A2
SCHEMBL26363520 0.91 PIM3 (0.40) PIM3LIMK1ROCK1CYP1A2NR1I3
SCHEMBL22161555 0.90 PIM3 (0.40) PIM3LIMK1ROCK1CYP1A2NR1I3
SCHEMBL25818528 0.89 PIM3 (0.38) PIM3F9LIMK1ROCK1CYP1A2
SCHEMBL22076582 0.88 GPR3 (0.38) PIM3LIMK1ROCK1CYP1A2NR1I3
SCHEMBL23437787 0.88 GPR3 (0.38) PIM3LIMK1ROCK1CYP1A2NR1I3
SCHEMBL25818483 0.88 KDM4E (0.34) PIM3HSD17B1HSD17B2F9CYP1A2
SCHEMBL22073886 0.87 PIM3 (0.40) PIM3F9LIMK1ROCK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 PIM3 3432/4885HSD17B1 3460/4885HSD17B2 2761/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 PIM3 3432/4885HSD17B1 3460/4885HSD17B2 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.